Biomarker & Pharmacodynamic (PD) Assay Development

  • ELISA and Multiplex Immunoassays
  • Proteomic Readouts and Clinical Pathology Panels

Develops and validates biomarker and PD assays that quantify biological effects, supporting efficacy evaluations, mechanism-of-action studies, and translational modelling.

Scroll to Top